Evaluation of clinical parameters of patients with Covid-19 pneumonia on admission and medications used for their comorbidities

Authors

  • Murat Civan Assistant Professor , Nisantasi University, Vocational School of Health Services, Sariyer, Istanbul, Turkey, Assistant Professor, Vital Hospital , Department of Cardiology, Bahcelievler, Istanbul, Turkey https://orcid.org/0000-0002-6006-2778
  • Hasan Haciosman Assistant Professor , Nisantasi University, Vocational School of Health Services, Sariyer, Istanbul, Turkey, Assistant Professor, Vital Hospital, Department of Internal Medicine, Bahcelievler, Istanbul, Turkey https://orcid.org/0000-0002-8949-5198

DOI:

https://doi.org/10.3126/ajms.v12i5.36109

Keywords:

Covid-19, Angiotensin converting enzyme inhibitors, Angiotensin receptor blockers, Non-steroidal anti-inflammatory drugs, Proton pump inhibitors

Abstract

Background: Risk factors and molecular mechanisms of severe respiratory involvement of Covid-19 are investigated more intensely and some doubts about non-steroidal antiinflammatory drugs (NSAID) and renin-angiotensin-aldosterone system (RAAS) inhibitors has also emerged.

Aims and Objective: We aimed to detect potential associations between medications taken regularly for comorbid diseases before the diagnosis of Covid-19 pneumonia and demographic or clinical features on admission.

Materials and Methods: Patients diagnosed with pneumonia between March 11th, 2020 and April 15th, 2020 in emergency, internal medicine and cardiology outpatient clinics were recruited and their clinical and demographic features including blood tests, oxygen saturations (SO2) along with degree of lung infiltrations in computed tomography on admission were analyzed in regard to their medications used regularly.

Results: Angiotensin converting enzyme inhibitors (ACE inh.) or angiotensin receptor blockers (ARB) users were older than no-ACE inh./ARB group and had significantly lower SO2 on admission, whereas NSAID users with Covid-19 displayed a marked female predominance and lower hemoglobin levels than no-NSAID group. Proton pump inhibitor (PPI) users had also a significant female predominance and older age with lower hemoglobin levels. Lastly, antiaggregant users with Covid-19 had a lower SO2 on admission and overall, cases with regular drug intake were markedly associated with older age.

Conclusion: Noteworthy associations were observed between demographic and clinical features on admission for Covid-19 pneumonia and major drug groups used regularly including RAAS inhibitors, NSAIDs and proton pump inhibitors.

Downloads

Download data is not yet available.
Abstract
309
PDF
331

Downloads

Published

2021-05-01

How to Cite

Civan, M., & Haciosman, H. (2021). Evaluation of clinical parameters of patients with Covid-19 pneumonia on admission and medications used for their comorbidities. Asian Journal of Medical Sciences, 12(5), 15–20. https://doi.org/10.3126/ajms.v12i5.36109

Issue

Vol. 12 No. 5 (2021)

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).